Zanotti Katherine S's Form 4/A amendment
AmendedExact Sciences Corp (EXAS) · filed Aug 3, 2021
- Accession no.
- 0001209191-21-049204
- Filed
- Aug 3, 2021
- Trade date
- Jul 30, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 2, 2021
This filing lists 1 non-derivative transaction. Open-market sales total $153.4K. It was filed 4 days after the trade.
This amendment replaces 0001209191-21-049078 (filed Aug 2, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zanotti Katherine SCIK 0001367313 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2021 | Common Stock | SSaleDisposed | −1,381 | $111.11 | −$153,442.91 | 34,741 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2020.
Remarks
On August 2, 2021 the reporting person filed a Form 4 to report certain sales made pursuant to a Rule 10bb5-1 trading plan entered into in November 2020 (the "Trading Plan"). This Form 4/A is being filed solely to denote that the reported sales were made pursuant to the Trading Plan.